by Skrydalewicz Maciej | Mar 30, 2020 | ECMO, Heart Surgery
BOSTON, MASSACHUSETTS – March 15, 2020 — BIOXYTRAN, INC., (OTC: BIXT) a developmental stage biotechnology company with a pipeline of anti-necrosis drugs designed to treat hypoxia by delivering a small molecule carrying oxygen to the brain of stroke victims...
